These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7646850)

  • 1. Unique peptide modifications involved in the biosynthesis of lantibiotics.
    Jack RW; Sahl HG
    Trends Biotechnol; 1995 Jul; 13(7):269-78. PubMed ID: 7646850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetics of lantibiotic biosynthesis.
    Jack R; Bierbaum G; Heidrich C; Sahl HG
    Bioessays; 1995 Sep; 17(9):793-802. PubMed ID: 8763832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of new class III lantibiotics--erythreapeptin, avermipeptin and griseopeptin from Saccharopolyspora erythraea, Streptomyces avermitilis and Streptomyces griseus demonstrates stepwise N-terminal leader processing.
    Völler GH; Krawczyk JM; Pesic A; Krawczyk B; Nachtigall J; Süssmuth RD
    Chembiochem; 2012 May; 13(8):1174-83. PubMed ID: 22556031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lantibiotics: insight and foresight for new paradigm.
    Nagao J; Asaduzzaman SM; Aso Y; Okuda K; Nakayama J; Sonomoto K
    J Biosci Bioeng; 2006 Sep; 102(3):139-49. PubMed ID: 17046525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttranslationally modified bacteriocins--the lantibiotics.
    Guder A; Wiedemann I; Sahl HG
    Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New developments in lantibiotic biosynthesis and mode of action.
    Patton GC; van der Donk WA
    Curr Opin Microbiol; 2005 Oct; 8(5):543-51. PubMed ID: 16118063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of subtilin and nisin biosyntheses: biosynthesis of lantibiotics.
    Entian KD; de Vos WM
    Antonie Van Leeuwenhoek; 1996 Feb; 69(2):109-17. PubMed ID: 8775971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis and biological activities of lantibiotics with unique post-translational modifications.
    Sahl HG; Jack RW; Bierbaum G
    Eur J Biochem; 1995 Jun; 230(3):827-53. PubMed ID: 7601145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity.
    Martin NI; Sprules T; Carpenter MR; Cotter PD; Hill C; Ross RP; Vederas JC
    Biochemistry; 2004 Mar; 43(11):3049-56. PubMed ID: 15023056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lantibiotic structures as guidelines for the design of peptides that can be modified by lantibiotic enzymes.
    Rink R; Kuipers A; de Boef E; Leenhouts KJ; Driessen AJ; Moll GN; Kuipers OP
    Biochemistry; 2005 Jun; 44(24):8873-82. PubMed ID: 15952794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics synthesized by posttranslational modification.
    Hansen JN
    Annu Rev Microbiol; 1993; 47():535-64. PubMed ID: 8257108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence analysis of lantibiotics: chemical derivatization procedures allow a fast access to complete Edman degradation.
    Meyer HE; Heber M; Eisermann B; Korte H; Metzger JW; Jung G
    Anal Biochem; 1994 Dec; 223(2):185-90. PubMed ID: 7887461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curvopeptin: a new lanthionine-containing class III lantibiotic and its co-substrate promiscuous synthetase.
    Krawczyk B; Völler GH; Völler J; Ensle P; Süssmuth RD
    Chembiochem; 2012 Sep; 13(14):2065-71. PubMed ID: 22907786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lanthionine introduction into nukacin ISK-1 prepeptide by co-expression with modification enzyme NukM in Escherichia coli.
    Nagao J; Harada Y; Shioya K; Aso Y; Zendo T; Nakayama J; Sonomoto K
    Biochem Biophys Res Commun; 2005 Oct; 336(2):507-13. PubMed ID: 16143300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.
    Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K
    J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lantibiotics--unusually modified bacteriocin-like peptides from gram-positive bacteria.
    Bierbaum G; Sahl HG
    Zentralbl Bakteriol; 1993 Feb; 278(1):1-22. PubMed ID: 8518504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lantibiotics produced by lactic acid bacteria: structure, function and applications.
    Twomey D; Ross RP; Ryan M; Meaney B; Hill C
    Antonie Van Leeuwenhoek; 2002 Aug; 82(1-4):165-85. PubMed ID: 12369187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and biosynthesis of carnolysin, a homologue of enterococcal cytolysin with D-amino acids.
    Lohans CT; Li JL; Vederas JC
    J Am Chem Soc; 2014 Sep; 136(38):13150-3. PubMed ID: 25207953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-translational modifications during lantibiotic biosynthesis.
    Xie L; van der Donk WA
    Curr Opin Chem Biol; 2004 Oct; 8(5):498-507. PubMed ID: 15450492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial engineering of dehydro-amino acids and lanthionines in non-lantibiotic peptides.
    Moll GN; Kuipers A; Rink R
    Antonie Van Leeuwenhoek; 2010 May; 97(4):319-33. PubMed ID: 20140513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.